Beyond the Hype: Careviso's Data-Driven War on Healthcare's Red Tape

VIENNA, VA – June 05, 2026 – In the world of healthcare, few processes attract as much universal scorn as prior authorization (PA). It’s the administrative labyrinth that stands between a doctor’s recommendation and a patient’s treatment, consuming billions of dollars and countless hours. Against this backdrop, a recent announcement from healthcare technology firm careviso feels less like a corporate milestone and more like a significant strategic move in a long-fought battle. The company revealed its provider network has swelled to over 460,000 enrollments, a critical mass that signals a data-driven assault on one of the industry's most persistent and damaging bottlenecks.

While network growth is a common metric of success, careviso’s expansion is noteworthy for its scale and its specific target. This isn't just about getting bigger; it's about building the necessary infrastructure to systemically dismantle the inefficiencies of prior authorization. The company's momentum, with projections to exceed half a million providers by year's end, warrants a closer look at whether technology and scale can finally deliver meaningful relief to beleaguered providers and anxious patients.

Quantifying the Bottleneck

To appreciate the significance of any potential solution, one must first grasp the sheer scale of the problem. Prior authorization has devolved from a cost-control checkpoint into a major impediment to care. According to industry studies, physicians and their staff spend, on average, the equivalent of two full workdays—up to 16 hours—each week navigating PA requirements. This administrative quicksand doesn't just drive up operating costs; it's a leading contributor to physician burnout, pulling skilled clinicians away from patient care to serve as clerks and negotiators.

The impact on patients is even more alarming. An overwhelming 94% of physicians report that PA processes lead to delays in necessary medical care. These aren't minor inconveniences. A third of physicians report that these delays have resulted in a serious adverse event for a patient, including hospitalization, permanent impairment, or death. Faced with these hurdles, a staggering 78% to 82% of patients simply abandon their recommended course of treatment altogether. In a system designed to heal, the process itself is causing harm.

A Network Approach to Untangling Red Tape

Careviso's strategy appears rooted in the understanding that a fragmented problem requires a unified solution. By enrolling a vast network of providers onto its seeQer platform, the company creates a standardized channel for managing what is currently a chaotic, payer-specific mess. The company’s rapid growth, which saw its network more than double in the last 18 months, suggests a strong market pull for its approach.

"As healthcare continues to face increasing administrative complexity, providers are looking for solutions that reduce burden and improve efficiency," said Andrew Mignatti, CEO and Co-Founder of careviso, in the company's announcement. "The rapid growth of our provider network demonstrates the trust physicians and healthcare organizations place in careviso to streamline prior authorization workflows and help patients access care faster."

Execution, not just ambition, is key. The company’s strategic focus is evident in its deep penetration into specialties disproportionately burdened by PA. Enrolling 61% of all U.S. endocrinologists, 57% of gastroenterologists, 50% of radiologists, and 45% of cardiologists isn't just about impressive numbers. It represents a concentrated effort to bring efficiency to the very clinical areas where delays can have the most significant consequences, building on the company's foundational strength in OB/GYN and oncology.

The XiFin Case Study: From Days to Hours

For any leader focused on execution, the central question is: does it work? Rhetoric about streamlining workflows is common; quantifiable proof is rare. Here, careviso offers compelling evidence through a case study conducted with XiFin, a leading AI-powered revenue cycle management (RCM) company. The study directly compared careviso’s performance against another PA vendor for the same client, a large national laboratory, providing a clear, head-to-head analysis.

The results are the kind of hard data that cuts through the noise. The study found that implementing careviso’s solution:

• Reduced the average time to submit a prior authorization by 48%, from 3.1 days down to 1.6 days.
• Slashed the average time to close a prior authorization case by 53%, from 8.1 days to just 3.8 days.

These metrics translate directly into faster patient access to critical diagnostic testing and subsequent treatment. For the laboratory, the operational improvements also had a significant financial impact, leading to a 13.5% increase in paid claims and an average revenue lift of over $347 per procedure. This is the tangible return on investment that demonstrates a shift from a cost center (managing PAs) to a value-driver (efficiently delivering care).

Under the Hood: The seeQer Platform and 'PA Submit Right'

These results are not achieved through manpower alone, but through a purpose-built technology platform. Careviso’s seeQer platform attacks the problem on two fronts: automating the PA process and providing critical financial transparency. The latter is a key differentiator, giving patients and providers real-time cost estimates to prevent the “sticker shock” that leads many to abandon care.

Recent enhancements show a commitment to tackling the most frustrating details of the process. The company just released 'PA Submit Right,' a tool designed to decode the labyrinth of payer submission pathways and point administrative teams to the precise digital or manual location for each submission. This seemingly simple function solves a major source of errors and delays, eliminating the time-consuming guesswork that plagues provider offices.

Furthermore, the platform has expanded its pharmacy benefit capabilities, integrating medical and pharmacy benefit visibility into a single workflow. This is crucial for specialty drugs and complex therapies where coverage can be split across different benefit plans, creating another layer of administrative friction. By providing an end-to-end view, the platform prevents the need for staff to log in and out of multiple, disparate systems.

"Prior Authorizations remains one of the most significant administrative challenges in healthcare," Mignatti stated. "At careviso, we remain committed to building solutions that simplify the process for providers, improve transparency, and ultimately create a better experience for patients." By backing this commitment with a rapidly scaling network and technology that delivers quantifiable results, the company is making a credible case that it can execute on one of healthcare's most intractable challenges.